Tyrosine Kinase Inhibition: A complete shut down of the neovascularization pathway is the goal

Research output: Contribution to journalArticle

Abstract

Targeting the "fuel injector" of neovascularization (tyrosine kinase) appears to make sense. There is some initial anatomic validation to tyrosine kinase inhibition, but the devil lies in the details. Whether this route is the answer that will help change the way we treat retinal disease in the future is yet to be determined.

Original languageEnglish (US)
Pages (from-to)3-4
Number of pages2
JournalRetina Today
Issue numberAUGUST-SUPPL.
StatePublished - Jul 1 2010

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Tyrosine Kinase Inhibition: A complete shut down of the neovascularization pathway is the goal'. Together they form a unique fingerprint.

Cite this